The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes?
Mona ElbalshySara BoucherBarbara GallandJillian J HaszardHamish CrocketEsko WiltshireCraig JefferiesMartin I de BockPaul TomlinsonShirley JonesBenjamin John WheelerPublished in: Journal of diabetes and metabolic disorders (2020)
The results of this study will provide much needed clinical trial data regarding DIY-CGM effectiveness in reducing parental FOH, as measured by HFS, as well as various other secondary outcomes including traditional glycaemic metrics, and child and caregiver sleep. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN 12619001551189) on 18 November 2019, and the World Health Organisation International Clinical Trial Registry Platform (Universal Trial Number U1111-1236-9189).
Keyphrases
- clinical trial
- type diabetes
- phase ii
- phase iii
- study protocol
- open label
- healthcare
- randomized controlled trial
- mental health
- public health
- young adults
- double blind
- cardiovascular disease
- physical activity
- metabolic syndrome
- systematic review
- insulin resistance
- machine learning
- risk assessment
- skeletal muscle
- glycemic control
- depressive symptoms
- single cell